OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumor mutational burden predictability in head and neck squamous cell carcinoma patients treated with immunotherapy: systematic review and meta-analysis
Juan P. Rodrigo, Mario Sánchez‐Canteli, María Otero‐Rosales, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Juan P. Rodrigo, Mario Sánchez‐Canteli, María Otero‐Rosales, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Showing 8 citing articles:
Towards the Prediction of Responses to Cancer Immunotherapy: A Multi-Omics Review
Weichu Tao, Qian Sun, Bingxiang Xu, et al.
Life (2025) Vol. 15, Iss. 2, pp. 283-283
Open Access
Weichu Tao, Qian Sun, Bingxiang Xu, et al.
Life (2025) Vol. 15, Iss. 2, pp. 283-283
Open Access
Evaluating the efficacy and safety of immune checkpoint inhibitors in first and second-line treatments for recurrent and metastatic head and neck squamous cell carcinoma: a systematic review and network meta-analysis of RCTs with a focus on PD-L1 expression
Wei Chen, Qichun Wei, Tong Xiao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Wei Chen, Qichun Wei, Tong Xiao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Releasing the brakes: the role of immune checkpoint inhibitors in laryngeal cancer
Michail Athanasopoulos, Pinelopi Samara, George Agrogiannis, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Michail Athanasopoulos, Pinelopi Samara, George Agrogiannis, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Multi-Omics Analysis of Tislelizumab Plus Nab-Paclitaxel and Cisplatin as Neoadjuvant Immunochemotherapy for Locally Advanced Hypopharyngeal Squamous Cell Carcinoma: A Prospective Single-Arm Phase 2 Trial
Lin Gui, Zucheng Xie, Wen Zhang, et al.
(2024)
Closed Access
Lin Gui, Zucheng Xie, Wen Zhang, et al.
(2024)
Closed Access
Letters to editor regarding the article “P4HA2 contributes to head and neck squamous cell carcinoma progression and EMT through PI3K/AKT signaling pathway”
KLG Afeeza, S. Balachandran, Muthamizh Selvamani, et al.
Medical Oncology (2024) Vol. 41, Iss. 9
Closed Access
KLG Afeeza, S. Balachandran, Muthamizh Selvamani, et al.
Medical Oncology (2024) Vol. 41, Iss. 9
Closed Access
Overall survival prediction of gastric cancer using the gene signature of CT-detected extramural venous invasion combined with M2 macrophages infiltration
Hao Yang, Xinyi Gou, Caizhen Feng, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
Hao Yang, Xinyi Gou, Caizhen Feng, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
Biomarkers in head and neck squamous cell carcinoma: unraveling the path to precision immunotherapy
Kamal S. Saini, Sasikala Somara, Heidi Ko, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Kamal S. Saini, Sasikala Somara, Heidi Ko, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Efficacy and safety of cemiplimab in cutaneous squamous cell carcinoma on chronic wounds: a French retrospective study
M. Antoszczak, E. Maubec, Ab. Duval-Modeste, et al.
EJC Skin Cancer (2024), pp. 100273-100273
Open Access
M. Antoszczak, E. Maubec, Ab. Duval-Modeste, et al.
EJC Skin Cancer (2024), pp. 100273-100273
Open Access
